Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
종목 코드 GELS
회사 이름Gelteq Ltd
상장일Oct 29, 2024
CEOMr. Nathan Jacob Givoni
직원 수7
유형Ordinary Share
회계 연도 종료Oct 29
주소Level 4
도시MELBOURNE
증권 거래소NASDAQ Capital Market Consolidated
국가Australia
우편 번호3205
전화61390873990
웹사이트https://www.gelteq.com
종목 코드 GELS
상장일Oct 29, 2024
CEOMr. Nathan Jacob Givoni
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음